Christopher Gaida

Prescriptions data shows one antibiotic course reshapes gut microbiome for years, depleting Bacillota and guiding smarter prescribing.

Doctors warn recent vaccine policy shifts may leave infants and underserved kids unprotected, raising RSV and measles risks and widening disparities.

New cardiology guidance refines dyslipidemia care with PREVENT risk scoring, LDL cholesterol targets, and add-on lipid therapies to cut ASCVD events.

Sputum flow cytometry identifies biologic targets (CD124/CD125) to personalize asthma and COPD treatment.

New real-world evidence links GLP-1RAs to lower acute care use and fewer treatment escalations than topiramate for chronic migraine.

75.5% of pediatric food-allergic patients possess multiple concurrent allergies across three distinct clinical clusters, underscoring the importance of expanded allergy screening.

Barzolvolimab demonstrates sustained, disease-modifying efficacy in antihistamine-refractory chronic spontaneous urticaria.

Swallowable gastric balloon, approved by the FDA, provides a non-invasive, surgery-free weight loss solution for patients with a BMI between 30 and 40.

Phase 3 data from KALOS and LOGOS trial support triple therapy in uncontrolled asthma, for both adolescents and adults.

A new study with infants reveals that those from vegetarian households follow growth trajectories nearly identical to their omnivorous peers by the age of 2.

Prenatal aspirin lowers severe preeclampsia 29% in high-risk pregnant patients; cardiology-driven prevention proves safe with direct dispensing.

New guidance urges primary care to spot early heart failure risk using simple biomarkers, helping prevent hospitalizations and improve outcomes.

Study finds many Medicaid-enrolled doctors see zero patients, worsening access and overloading others—especially in psychiatry and primary care.